A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
about
Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregationMeloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteersCoxibs and cardiovascular riskIs there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksA computer simulation of progesterone and Cox2 inhibitor treatment for preterm labor.The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies.Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.Mechanistic insights into a classic wonder drug--aspirin.Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprainDual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.Etoricoxib for arthritis and pain managementRofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood.Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.Gastrointestinal effects of aspirin.Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors.Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes.Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1.Nitrooxyacyl derivatives of salicylic acid: aspirin-like molecules that covalently inactivate cyclooxygenase-1.Roles of NSAIDs and aspirin in bleeding peptic ulcers : NSAIDs, aspirin and peptic ulcers.Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.Evaluative comparison of systemic aspirin therapy effects on gingival bleeding in post non-surgical periodontal therapy individuals.Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans.Characterization of etoricoxib, a novel, selective COX-2 inhibitor.COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited.Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity
P2860
Q27658412-12B8BDBA-D58A-4D39-B5F9-2E144E1B3954Q28165301-0CD0D3B2-3B07-4A4E-857C-F76C76593AE7Q28168971-FF78331B-A854-4554-96EA-D507EBAA2304Q28192582-6282D20C-DDA4-41BF-9E03-0561D828ECB2Q28196511-2EFC3D32-A0D1-432B-8596-5D43ABB7860DQ28198746-96238B27-5802-426E-BE5C-68FFB775CB42Q30234292-749A12B4-293D-4253-A6CC-4F1EDBFA728DQ30629677-D4DA7DAF-52B8-4875-A950-245931ECB8C1Q30977313-32E9A0EA-B628-4122-8DBA-6BC220081AD4Q33440652-70B3F9EB-EB2D-4E8A-9F9C-642B939DD607Q34530950-D4DF4CF6-BBD6-4901-AC83-9A1CE24A21A3Q34601141-AD469F75-AAC6-4788-B5DA-EF8E9B4C788CQ35021715-0DA309C1-F83C-4AE7-8114-347DE5B02105Q35033343-7540073B-A8D3-45A6-9218-ED5A8006A253Q35100868-1C811FBF-705A-40C8-AC4B-C98FCB67CFCDQ35166773-F7242CB8-6B61-4E6F-BBBA-6E2553BFAE34Q35195182-5E878F54-9E0C-4BCB-880A-F2D1247D8212Q35860889-0A10E93A-A456-426E-8E35-414C601A92C6Q36035412-09DEAA9D-0F0E-447D-AE67-D9FAD9F4CED9Q37885723-68EDEFF1-8673-4FC0-BE2D-687A37D018F8Q37893966-5D76CB49-21A4-4493-8E22-14E2566E10BEQ38249105-85ABFDCD-0B30-4334-B577-3605D16763A2Q38259405-23ED0065-36D2-4F68-8C99-8C5ED5DD9BBEQ39314986-AB392D5D-6FE0-4572-BD6C-A839A7BD4B49Q39584172-C2A4CF6C-9BF2-45B7-BB9E-C9377E15ADBEQ40086146-86A799F7-2180-4DEB-9117-B3E7DE754AA8Q41256836-EC872EF1-66C6-4A61-9E05-261D2C00E124Q41882213-ACDD3103-9271-405B-BE5A-271A18B49CA4Q44482222-94F0C7CC-C59C-42B3-B903-1E421E7737B6Q44484802-3DEA33C2-ADED-4679-A6FD-04B4A093EEBEQ46061276-2352B066-F68E-4711-9533-6DED58E08D38Q47372560-114A34C8-2CA7-41CD-8B65-D357A1F6CEE5Q57169425-4FD128F7-8BA5-4F32-8905-E8B71936B104
P2860
A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@ast
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@en
type
label
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@ast
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@en
prefLabel
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@ast
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@en
P2093
P2860
P356
P1476
A high level of cyclooxygenase ...... nase-1 inactivation by aspirin
@en
P2093
D Riendeau
M D Percival
P2860
P304
14583-14588
P356
10.1073/PNAS.251543298
P407
P577
2001-11-20T00:00:00Z